Serotonin, Impulsivity, and Cocaine Dependence Treatment
The purpose of this study is to compare the effects of citalopram versus placebo given in the context of contingency management for cocaine dependence.
|Study Design:||Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Primary Purpose: Treatment
|Official Title:||Serotonin, Impulsivity, and Cocaine Dependence Treatment|
- The presence of cocaine metabolites in urine weekly.
- Retention rate and cocaine cravings weekly.
|Study Start Date:||April 2001|
|Estimated Study Completion Date:||November 2004|
Cocaine dependence continues to be a significant public health problem, for which there is no FDA approved pharmacotherapy. This study is a 12-week, double blind, placebo controlled trial of citalopram for cocaine dependence. The primary outcome measure is benzoylecgonine positive urines. Secondary measures of side effects and craving are also examined.
|United States, Texas|
|University of Texas – Houston Health Science Center|
|Houston, Texas, United States, 77030|
|Principal Investigator:||Frederick G Moeller, M.D.||The University of Texas Health Science Center, Houston|